EUROIMMUN develops ELISAs for detection of anti-CCHFV antibodies for acute outbreak support
Crimean-Congo haemorrhagic fever (CCHF) is a life-threatening tick-borne viral disease which is included in the World Health Organisation priorities for research and product development for early diagnostics. Since there is no CCHF vaccine available, management of outbreaks relies on rapid identification of cases and appropriate infection control measures.